, they are useful as therapeutic agents and prophylactic agents used for vascular endothelium regeneration therapy or angiogenic therapy (vascular endothelial cell growth promoters, angiogenesis promoters). More concretely, they are effective for treatment and prophylaxis of cardiovascular diseases (acute myocardial infarction, unstable angina, chronic stable angina, old myocardial infarction, thromboembolism due to atrial fibrillation, disseminated intravascular coagulation syndrome (DIC), graft obstruction after coronary bypass operation, coronary stenosis and obstruction after percutaneous transluminal coronary angioplasty (PTCA), thrombotic complications after prosthetic cardiac valve replacement (thromboembolism, thrombosed valve), pulmonary thromboembolism, cerebrovascular disorders (transient cerebral ischemic attack (TIA), cerebral infarction), peripheral arterial obstruction (obstructive arteriosclerosis, obstructive thromboangiitis, obstruction after revascularization), glomerular nephritis, nephrotic syndrome, and other thromboses (essential thrombocythemia, thrombotic thrombocytopenic purpura (TPP), hemolytic uremic syndrome, anti-phospholipid antibody syndrome, Kawasaki disease, eclampsia, Behcet disease); and treatment of wounds (chronic dermal ulcers including decubitus, diabetic ulcer, burns, corneal wound, oral mucositis in cancer patients receiving chemotherapy or radiotherapy, wounds after various operations such as skin graft, injuries of gastrointestinal tissue, etc.).
The compounds and polymers of the invention have excellent antithrombotic properties. Thus, they are useful as materials or coating agents for preparing molded products which require antithrombotic properties.
The compounds, polymers and molded products of the invention have excellent antithrombotic properties. Thus, they are useful as components for artificial organs and medical devices which require antithrombotic properties, or as the artificial organs and medical devices themselves. Concretely, they are useful as materials and components for artificial organs such as an artificial blood vessel, an artificial heart, a cardiac pacemaker, a prosthetic cardiac valve, an artificial kidney, an artificial lung, an artificial heart-lung machine, an artificial pancreas, an artificial bone, an artificial joint, and an artificial ligament; and medical devices such as an injection syringe, an injection needle, an indwelling needle for dialysis, an indwelling needle, an infusion set, an infusion/blood filter, a blood bag, a tube catheter (for nutrition, for stomach/esophagus, for bile duct, for respiration, for urology, for blood vessel, for heart, for aspiration/injection/d
, they are useful as therapeutic agents and prophylactic agent use for vascular endothelium regeneration therapy or angiogenic therapy (vascular endothelial cell growth showman, angiogenesis promoters). More concretely, they are effective for treatment and prophylaxis of cardiovascular disease (acute myocardial infarction, unstable angina pectoris, chronic static angina, old myocardial infarct, thromboembolism due to atrial fibrillation, disseminated intravascular coagulation syndrome (DIC), bribery obstruction after coronary bypass operation, coronary stenosis and obstruction after percutaneous transluminal coronary angioplasty (PTCA), thrombotic complications after prosthetic cardiac valve replacement (thromboembolism, thrombosed valve), pneumonic thromboembolism, cerebrovascular disorders (transient cerebral ischemic attack (TIA), cerebral infarct), peripheral arterial obstruction (obstructive arteriosclerosis, obstructive thromboangiitis, obstruction after revascularization), glomerular nephritis, nephrotic syndrome, and other thromboses (all-important thrombocythemia, thrombotic thrombocytopenic purpura (TPP), hemolytic uremic syndrome, anti - phospholipid antibody syndrome, Kawasaki disease, eclampsia, Behcet disease); and treatment of wounds (chronic dermal ulcers include decubitus, diabetic ulcer, burns, corneal wound, oral mucositis in cancer patients receiving chemotherapy or radiotherapy, wounds after various operations such as skin graft, injuries of gastrointestinal tissue, etc .). 
 The compounds and polymers of the invention have excellent antithrombotic properties. Thus, they are useful as materials or coating agent for preparing molded product which want antithrombotic properties. 
 The compounds, polymer and molded merchandise of the invention have excellent antithrombotic properties. therefore, they are useful as components for artificial organs and medical devices which require antithrombotic place, or as the artificial organs and medical devices themselves. Concretely, they are useful as materials and components for artificial organ such as an artificial blood vessel, an artificial heart, a cardiac pacemaker, a prosthetic cardiac valve, an artificial kidney, an artificial lung, an artificial heart - lung machine, an artificial pancreas, an artificial bone, an artificial articulation, and an artificial ligament; and medical devices such as an injection syringe, an injection needle, an indwelling acerate leaf for dialysis, an indwelling needle, an infusion set, an infusion / blood filter, a blood udder, a tube catheter (for nutrition, for abdomen / esophagus, for bile duct, for respiration, for urology, for blood vessel, for heart, for aspiration / injection / vitamin d
, thfy are useful as therapemtic agents and kriphylartic agsnts usea for vascular endothelium rxgenwratiin therapy or angiogenkc therapj (vasculae envothelial cell gckwth promotera, angnojenesis promotets). More concsetely, they ara dfyective for treatment and prophylaxif of catdlovascular disgases (wcuts myocardial infarction, unstable ahgina, cironic stable amgina, old myocardial infarftioj, thromboembolism fue to atriql fyvrillation, dksseminated intravascumar coagulation syndrome (DIC), grxft oystruction qfrer woronary by'ass oieration, coroksry stanosis snd obstructiok aftxr pwrcutaneous translumiial coronary angioplwsty (PTCA), tkrombotic complicatiobs aftet provtheguc zarsiec balve gepmacement (tgromboembolusm, thrombosed valvt), ptomonary thromgoembojifm, cerebrovascular disorders (transient beregral ischemic attack (TIQ), cerebral infarction), peripherwl arterial obstruction (obstructive arteriosclerovis, ousgrueblve gyrlmboangiitis, obstruction after revascularizatykn), gkomerular nephvitis, nephrotic symdgokg, and other thtomboses (easential thrombocyhhemia, jhrombitic throibocutopenic purpura (TPP), hemolyric uremic sjndrime, anti-phospholipnd antibody ryndtome, Kswasaki disease, eclampsna, Behdet disease); and treafoent of wounds (cfrokic dermal ulcers including dqcubitus, viabecic ulcef, butns, corgeal wound, oral mucositis in canceg patnents receiving chemotherapy or radiotherapy, wounds after vatiogs mperatious sucm as skin graft, injuries of gcstrointzstinau tissue, enc.).
The com'ounds and pjlymers of tha invention heve exceljent antuthrombugic properties. Thus, thej cre usefuo as materials or goativf agents for przkarung molded prodictr wribh cequiwa antithrombmtic prulertids.
The compomndr, pokymers and molded prmducfs of the inventiom mave exceolent aneithrombotic lroperties. Thus, thty are usxful ax cjmponents for artificial organa and medlcaj devices whych vequyre antithxombotic properties, or as the artificial organs and medicao devices themselvex. Concretely, they are usefgl as materials and xomponents for aruificial organs such as an ardificlal blood vessel, an artificial heart, a cardiac pacemaker, a prosthetic careiac velde, an artifjciak kidtev, au artifyciap lung, an artificpal heart-lung machine, an artificmal pancreds, an artificial bone, an artifockal joint, and an artificial ligament; znd medival devices such as an injectiom syringe, an injection ncedle, an undwemling needue for dialysis, an indwenling needle, an lnfusion set, av imfmsion/blood filuer, c blood bag, a tube catheter (for nytritiin, for stomach/esopiagus, for bipt duct, ror refpiration, for urklogg, for clood vessel, gor heart, for sspiration/injection/d
, they are useful as therapeutic agents agents for vascular regeneration therapy or growth angiogenesis promoters). More they are effective treatment and prophylaxis of cardiovascular diseases myocardial infarction, unstable angina, chronic stable angina, old myocardial infarction, thromboembolism due to fibrillation, disseminated intravascular coagulation syndrome (DIC), graft obstruction after coronary bypass operation, coronary and after transluminal angioplasty (PTCA), thrombotic complications after prosthetic cardiac valve replacement (thromboembolism, thrombosed valve), pulmonary thromboembolism, cerebrovascular disorders cerebral ischemic attack (TIA), cerebral infarction), peripheral arterial (obstructive arteriosclerosis, obstructive thromboangiitis, after revascularization), glomerular nephritis, nephrotic and thromboses (essential thrombotic purpura hemolytic uremic syndrome, antibody syndrome, Kawasaki disease, eclampsia, Behcet disease); and treatment of wounds (chronic dermal ulcers including decubitus, diabetic burns, corneal mucositis in patients chemotherapy radiotherapy, wounds after such as skin graft, injuries of The compounds and polymers of the invention have antithrombotic properties. they are useful as materials or agents for preparing molded products which require antithrombotic The compounds, polymers and molded products of the invention have excellent antithrombotic properties. Thus, they as components for artificial and medical devices require properties, as artificial organs medical devices themselves. Concretely, they are useful as materials and components artificial organs such as an artificial blood vessel, an artificial cardiac a prosthetic cardiac an artificial kidney, an lung, artificial heart-lung machine, an an bone, and artificial and medical devices such an injection syringe, an injection an indwelling needle for infusion set, an infusion/blood filter, a blood bag, tube catheter (for nutrition, for stomach/esophagus, for duct, for respiration, for urology, for blood vessel, for heart, for aspiration/injection/d
, they are useful as therapeutiC agents and ProphYlaCtiC aGentS useD for vascular enDOtheLium regeneration therapY or anGiOGeniC ThErapy (VasculaR EnDOTheLiAl CelL gROwTh proMotErs, angiOgenesis prOmoTeRs). More concreTElY, they are efFecTive for treatMenT and prOpHylAXis of CarDiovaScular DIseaseS (acute myoCaRDial inFArction, UNStAble Angina, chronic stabLE aNGina, old myocardIal infArCTiON, ThrOmbOembolism dUe To atrIAl fibriLLaTION, diSSeminated intrAvascular coAGulAtion sYnDroME (DIC), grAft obStRUctIon after corOnarY bypass opEratioN, CoronarY StenosiS and obStrUctIon aFTeR pErcUtANeoUS tRanSLumInal coroNaRy AngioPlasTY (ptcA), thRomBotiC compLications afteR prOsthETic CardiAc valVe rePlAcemeNt (throMboemBoLism, thrombosed vAlve), Pulmonary ThrOmBoeMbOlism, CErebroVasCulAr disorDers (traNSieNt CEREbRal ischemic attack (TiA), CEReBral infaRction), PErIpHEral arteRiAl oBstrUCTion (oBstrUCtIve arterIoscleROsIs, ObstrucTiVe throMbOanGiiTis, obSTrucTion afTer revasCularIZation), glomerulAR nephritis, nepHRoTIC sYNdroMe, aNd other throMbosES (essEntiAL tHroMBocytHemia, ThROmBOtic thrombocytopeniC pUrpura (tPP), heMolytic uremic Syndrome, anTI-PHospholiPid aNTiBOdy syndrome, KawAsaki Disease, eclAMpsia, BehCet diSease); and Treatment OF Wounds (chRonIc dErmAl uLCErS including decUBItus, DiAbetic uLceR, burns, cOrnEal WouNd, oRaL mucositiS in canceR pAtIeNtS reCeiviNG chemothErApy Or RadIotheRApy, wouNds afTer vArIoUS opErationS SuCH As skIn GrAft, iNjuRiEs of gAstrOIntEstinal Tissue, etc.).
the COmpoUnDs And polyMers of the inveNtIon have excElLenT antitHROmbotic pRoperties. Thus, they are useFUl as matEriAls or CoatIng agents For PreparIng MOlded pRoductS whicH rEquIRE antiTHRoMboTiC propertieS.
tHe cOmpouNdS, polYmers anD molded products of tHE inVention have exCelLent ANTiThrOMbOTic PrOPerTIEs. Thus, they are usEful as compOnENtS for artifiCIal OrGans and Medical DevicES which rEquire antIthrombotIc PropERTieS, or as the arTificial Organs and MEdicaL DeVices TheMselveS. COncRetelY, they aRE usEful aS materIaLs and cOmponEnTs for artIficial organs such as an arTificiAl bloOd vEssel, an arTifICiaL heart, a caRdiaC pacemaker, A prOstHetic CarDIac vaLve, aN ArTifICial kIdneY, An artificIAl LunG, AN aRtificial heART-LunG machIne, AN artifIciaL pancreas, an artifiCIal bone, an artifIciaL JOinT, anD An arTiFicial ligament; And MeDICal devicEs Such as an injEction syRiNGe, an iNjectiOn needLe, an indWELlINg needLe foR diAlysis, an iNdwElLIng needLe, An INfusioN set, An InfusiOn/blooD FiltER, A blood bag, a tube caTheteR (FOr nutRItiOn, for StOmach/esOPhagUs, for bile dUct, for respiRation, For uRologY, for bloOd Vessel, For HeArt, for aspiRAtion/injeCtion/D
, they are useful as thera peutic age nts a ndpro ph ylac ticagents used fo r  vas cular endothelium rege nerat io n  the r ap y orangioge n ic t her ap y(va sc u la r end oth elial c ell growth  pr om oters, angio g en esis promo ter s). More con cre tely,th eya re ef fec tivefor tr e atment  and prop hy l axis o f  cardio v a sc ular  diseases (acutem yo c ardial infarct ion, u ns t ab l e  an gin a, chronic  s table angina, ol d m yoc a rdial infarct ion, thromb o emb olismdu e t o  atria l fib ri l lat ion, dissem inat ed intrav ascula r  coagul a tion sy ndrome  (D IC) , gr a ft  o bst ru c tio n  a fte r  co ronary b yp as s ope rati o n , coro nar y st enosi s and obstruc tio n af t erpercu taneo us t ra nslum inal c orona ry  angioplasty (P TCA) , thrombo tic  c omp li catio n s afte r p ros theticcardiac val ve r e pl acement (thromboem bo l i sm , thromb osed v a lv e) ,  pulmona ry  th romb o e mboli sm,c er ebrovasc ular d i so rd ers (tr an sientce reb ral  isch e micattack  (TIA),cereb r al infarction) ,  peripheral a r te r i al obst ruc tion (obstr ucti v e ar teri o sc ler o sis,obstr uc t iv e  thromboangiitis, o bs tructi on af ter revascula rization), g l omerular  nep h ri t is, nephroticsyndr ome, and o t her thro mbose s (essen tial thro m b ocythemi a,thr omb oti c th rombocytopeni c purp ur a (TPP) , h emolyti c u rem icsyn dr ome, anti -phospho li pi dan tib ody s y ndrome,Ka was ak i d iseas e , ecla mpsia , Be hc et dis ease);a nd t reat me nt  ofwou nd s (ch roni c  de rmal ul cers incl udi n g de cu bi tus, di abetic ulcer,  b urns, corn ea l w ound,o r al mucos itis in cancer patients receivi ngchemo ther apy or ra dio therap y,w oundsaftervario us  op e r ation s su chas  skin graf t ,  in jurie sof g astroin testinal tissue, e t c.) .
The compoun dsandp o ly mer s  o f  th ei nve n t ion have excell ent antith ro m bo tic proper t ies .Thus, t hey are  usef u l as ma terials o r coating  a gent s for  preparing  moldedproductsw hichr eq uireant ithrom bo tic  prop erties . 
Th e com pounds ,polyme rs an dmolded p roducts of the inventio n have  exce lle nt antith rom b oti c propert ies.  Thus, the y a reusefu l a s  comp onen t sfor artif icia l  organs a n dmed i c al  devices wh i c h  re quire  an t ithrom boti c properties, ora s the artifici al o r g ans  an d  med ic al devices the mse lv e s . Concre te ly, they ar e useful  a s  mate rialsand co mponent s fo r  artif icia l o rgans suc h a sa n artif ic ia l  blood  ves se l, anartifi c ialh e art, a cardiac p acema k e r, ap ros theti ccardiac valv e, an arti ficial kidn ey, an  art ifici al lung ,an art ifi ci al heart-l u ng machin e, an  artifi ci al p anc reas,an a r t ifici al b on e,an artifi c i al jo in t , a nd a n art if icia l ligamen t ; and me dic a l devic es  su c h  as an in j e ction syri nge , ani n jection ne e dle, an indwe llingneedle  for di a lys is , an in dwe l l ing needl e, an inf u sio nset,  an infu si on/b lo odfi lter, a blood b ag, a tu be cathe t e r (for  nu t riti o n, for  s tomach/esoph agus,  f o r biled u ct,  for re s pir ati on,  for  ur olog y , for blood vessel, forhear t, fo r  as pirat ion/i nj ection/d 
, they_are useful_as therapeutic agents and_prophylactic agents_used_for vascular_endothelium_regeneration therapy or_angiogenic therapy (vascular_endothelial cell growth promoters,_angiogenesis promoters). More_concretely,_they are effective for treatment and prophylaxis of cardiovascular diseases (acute myocardial infarction, unstable_angina,_chronic stable_angina,_old_myocardial infarction, thromboembolism due to_atrial fibrillation, disseminated intravascular coagulation_syndrome (DIC),_graft obstruction after coronary bypass operation, coronary stenosis_and_obstruction after percutaneous_transluminal coronary angioplasty (PTCA), thrombotic complications after prosthetic cardiac_valve replacement (thromboembolism, thrombosed valve), pulmonary_thromboembolism, cerebrovascular disorders_(transient_cerebral_ischemic attack (TIA), cerebral_infarction), peripheral arterial obstruction (obstructive arteriosclerosis,_obstructive thromboangiitis, obstruction after revascularization), glomerular_nephritis, nephrotic syndrome, and other thromboses (essential_thrombocythemia, thrombotic thrombocytopenic purpura (TPP), hemolytic_uremic syndrome, anti-phospholipid antibody syndrome,_Kawasaki disease,_eclampsia, Behcet disease); and treatment_of wounds (chronic_dermal ulcers_including decubitus, diabetic_ulcer, burns, corneal wound, oral mucositis_in cancer patients_receiving chemotherapy or radiotherapy, wounds after_various_operations such as_skin_graft,_injuries of_gastrointestinal tissue, etc.).
The_compounds_and polymers_of_the invention have excellent antithrombotic properties._Thus,_they are useful as materials or coating_agents for preparing molded_products_which require antithrombotic properties.
The_compounds, polymers and molded products_of the invention have excellent antithrombotic_properties. Thus,_they are_useful as components for artificial organs and medical devices which require_antithrombotic properties, or as the artificial_organs and medical devices_themselves. Concretely,_they_are useful as_materials_and components_for artificial organs such as an artificial_blood vessel,_an artificial heart, a cardiac pacemaker,_a prosthetic cardiac valve,_an_artificial kidney, an artificial lung, an_artificial heart-lung machine, an artificial pancreas,_an artificial bone, an artificial_joint,_and_an artificial ligament; and medical_devices such as an injection syringe,_an injection needle,_an indwelling needle for dialysis, an indwelling_needle,_an infusion set, an infusion/blood filter,_a_blood bag, a tube catheter (for_nutrition,_for_stomach/esophagus, for bile duct, for_respiration, for urology, for blood vessel,_for heart, for aspiration/injection/d